Macrophage Derived Immunotherapy in Glioblastoma to Reprogram the Tumor Microenvironment
Time: 10:45 am
day: Conference Day 1
Details:
- Developing cell & gene therapy for solid tumors
- Reprogramming the tumor microenvironment (TME) using hematopoietic progenitor stem cells
- Designing combination I/O treatments taking advantage of the agnostic nature of the technology platform
